Diabetes and GP: “Reorganize the health system and give access to innovation to territorial medicine, only in this way will the general practitioner resume the central role of care”
“The pandemic has helped to reveal a criticality already known to those who deal with diabetes on a daily basis: the Italian health system, which tends to be unbalanced on taking care of the acute, is in difficulty when it comes to organizing efficient assistance in the area , and even more in developing a synergistic continuity of care between the territory and the hospital ”. This was stated by Paolo Di Bartolo, President of AMD during the webinar organized to take stock of the topic by Diabete Italia onlus and Motore Sanità and entitled Diabetes care and GP: a key player in the treatment process with blunt weapons, achieved thanks to the unconditional contribution from AstraZeneca and Boehringer Ingelheim, which saw the participation of leading Italian experts.
In fact, the pandemic has highlighted the fragility of territorial care in the treatment of diabetes: it is essential to reorganize the healthcare system and it is imperative to guarantee territorial medicine access to innovation, in fact the health benefits are slowing down with a consequent increase in social costs. welfare. The GP, general practitioner, must go back to being a prescriber, it is necessary to restore the territory to be central in the management of chronic diabetes. No less important, de-bureaucratizing many procedures that represent an unnecessary commitment for patients and family members and for the treating physician, removing him from clinical control and increasing waiting lists in local clinics.
“A new problem, because it was highlighted by Covid – continued Di Bartolo -, but the most age-old issue for the ‘insiders’. Today more than ever, it is evident the need to create a true integrated care network that takes into account the full involvement of General Practitioners in taking care of people with diabetes, extending, also to the latter, the possibility of prescribing drugs for diabetes therapy accompanying, finally, this decision with a no longer extendable abolition of the therapeutic plans. Such a reorganization of the current model of assistance would allow for a truly integrated management of the person with diabetes where each node can be connected thanks to a capillary digitization that guarantees effective data sharing (ed: today the systems available are often non-interoperable systems ) and where telemedicine can become part of the care pathway “.
“The Covid 19 pandemic – explained Stefano Nervo, President of Diabete Italia – has exacerbated and highlighted some latent problems of Italian health. We are confident that we can benefit from this pandemic situation and we want to be concrete in proposing challenges and improvements for the entire national health system. First of all, the treatment of diabetes absolutely needs a very efficient coordination between hospitals and the territory. We must improve patient adherence to therapies and counteract therapeutic inertia, using every drug and device available to date at full capacity. To do this we need the professionalism of general practitioners who must be put in the conditions to operate at their best, with the most appropriate tools for the management of the diabetic, chronically ill patient. We do not want heroic doctors or privileged patients, we do not want discrimination or differences between one region or another: we want a fair system that guarantees the highest quality and best performance to all diabetics throughout the country ”
“Type 2 diabetes mellitus is one of the most important and complex of chronic diseases that must be managed mainly at the local level. The GP is heavily involved in the management of people with DM2. The National Plan for Diabetic Disease provides for the prevalent care by GPs of subjects with stable disease and without developmental complications. Furthermore, diabetic patients permanently bedridden or not self-sufficient and with advanced degrees of disability, often with multiple pathologies, are necessarily followed at home only by their GP. The GP’s task is made very complicated not only by the workload, the complexity of the pathology and the rapid changes in scientific knowledge, but also by the fact that for some of the numerous hypoglycemic drugs available today, the prescription is conditioned by the compilation of the therapeutic plan by diabetologists, despite their excellent safety profile and proven cardiorenal protection supported by solid scientific evidence. So it happens that the very first line of territorial defense against the dreaded complications of diabetes finds itself fighting with scarce and inadequate weapons. A situation that is now unsustainable. Especially in this period in which some chronic diseases are a powerful risk factor for Covid-19. It is therefore necessary that family doctors be immediately allowed to use and prescribe all the therapeutic resources available for the good care of diabetes today. even more relevant as they are highly protective against Covid-19 ”, declared Gerardo Medea, National Head of SIMG research.
For the treatment of Type 2 diabetes choose Italy: it is better